Virtual Assistant Streamlines Regulatory Compliance
Digital Tools for Formulator
Lipid-Based Drug Delivery Systems Optimize Absorption
In Vitro and In Vivo Assessment of the Potential of Supersaturation to Enhance the Absorption of Poorly Soluble Basic Drugs
Using Empty AAV Capsids to Reduce Inhibitory Effect of Neutralizing Antibodies on AAV Transduction
Reducing Target Interference in Anti-Pembrolizumab Antibody Detection
Assessing Patient Exposure to Leachables
NfL as a Blood-Based Biomarker for Neurodegenerative Diseases
Simultaneous Measurement of Tanespimycin and its Active Metabolite in Human Plasma
Evaluating Plasticizers in Soft Gels
Potent API Development
Selection Methods for Addressing Bioavailability Challenges
Factors to Consider in Filter Validation in Pharmaceutical QC
Case study to demonstrate sensitivity in Immunogenicity Assay should be based on result of both screening and Confirmatory tier
Quantitation of Biotherapeutics via LC-MS
Effect of Freeze Thaw Cycles of Conjugated Reagents on Immunogenicity Assays
Characterizing Deformation Properties of Directly Compressible Excipients using a Compaction Emulator
Early Drug Development Decision-Making Tips
Effects of Excipients on Skin Delivery of Drugs and Actives
Subcutaneous Drug Delivery
Data as cGMP Records and Other Integrity Issues
Data Integrity Challenges
Maximizing the Effectiveness of Softgels Part 2
Maximizing the Effectiveness of Softgels Part 1
Sourcing APIs and Supply Chain Management
Accelerating the Pathways to Biologics, Part 2
Accelerating the Pathways to Biologics, Part 1
Lipid Formulations for Drug Development
Thought-Leadership Series Instant- and Modified-Release Dosage Forms, Part 3
Thought-Leadership Series Instant- and Modified-Release Dosage Forms, Part 2
